Although tumor neoantigen exposure was not specifically studied here, tumor rejections elicited by complete responder mice, as well as reduced efficacy of photoimmunotherapy among mice that received CD40/CD40L blockade, suggest that photoimmunotherapy enhances the expansion of tumor-specific immune responses. Here, CD40LG is linked to neoplasm.